FDA Drugs recall ·

Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL… recall

Recall number
D-0222-2025
Date
(initiated January 7, 2025)
Company / brand
Pharmaceutical Associates Inc
1700 Perimeter Rd, Greenville, SC, United States
Category
Drugs › Class III
Classification
Class III
Status
Terminated
Units affected
4080 Bottles
Hazard tags
Potency
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16

Why was it recalled?

Superpotent; sodium benzoate preservative

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot number 4B07, Exp Date: 2026-OCT-31

Distribution

OH

What does Class III mean?

Class III means use of or exposure to the product is not likely to cause adverse health consequences (for example, a labeling violation).

Source: FDA (drugs), recall D-0222-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.